A community of 30,000 US Transcriptionist serving Medical Transcription Industry
Does anyone know the BOS rule for drug names that are technically all caps, i.e., TUMS, GRALISE? Do they stay all caps or is it okay to capitalize just the first letter, or is it company/client preference? QA is telling me just to capitalize the first letter so as not to draw more attention than needed to the drug name in the report, but I can't document this in the Book of Style. Thanks in advance!